These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 17489974

  • 21. Efficacy of mycophenolate mofetil in adult refractory auto-immune cytopenias: a single center preliminary study.
    Kotb R, Pinganaud C, Trichet C, Lambotte O, Dreyfus M, Delfraissy JF, Tchernia G, Goujard C.
    Eur J Haematol; 2005 Jul; 75(1):60-4. PubMed ID: 15946312
    [Abstract] [Full Text] [Related]

  • 22. Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant.
    Kim JG, Sohn SK, Kim DH, Lee NY, Suh JS, Lee KS, Lee KB.
    Eur J Haematol; 2004 Jul; 73(1):56-61. PubMed ID: 15182339
    [Abstract] [Full Text] [Related]

  • 23. Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil.
    Martini G, Ramanan AV, Falcini F, Girschick H, Goldsmith DP, Zulian F.
    Rheumatology (Oxford); 2009 Nov; 48(11):1410-3. PubMed ID: 19713439
    [Abstract] [Full Text] [Related]

  • 24. Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults.
    Lyakhovitsky A, Barzilai A, Heyman R, Baum S, Amichai B, Solomon M, Shpiro D, Trau H.
    J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):43-9. PubMed ID: 19552716
    [Abstract] [Full Text] [Related]

  • 25. Mycophenolate mofetil in liver transplantation.
    McDiarmid SV.
    Clin Transplant; 1996 Feb; 10(1 Pt 2):140-5. PubMed ID: 8680052
    [Abstract] [Full Text] [Related]

  • 26. An analysis of the dermatological uses of mycophenolate mofetil in a tertiary hospital.
    George L, Hamann I, Chen K, Choi J, Fernandez-Peñas P.
    J Dermatolog Treat; 2015 Feb; 26(1):63-6. PubMed ID: 24286467
    [Abstract] [Full Text] [Related]

  • 27. Candida Esophagitis Associated With Mycophenolate Mofetil Treatment of Atopic Dermatitis.
    Kurayev A, Gottlieb AB.
    J Drugs Dermatol; 2016 Oct 01; 15(10):1267-1269. PubMed ID: 27741346
    [Abstract] [Full Text] [Related]

  • 28. Systemic Agents for Severe Atopic Dermatitis in Children.
    Notaro ER, Sidbury R.
    Paediatr Drugs; 2015 Dec 01; 17(6):449-57. PubMed ID: 26547214
    [Abstract] [Full Text] [Related]

  • 29. Immunosuppression based on mycophenolate mofetil in stable liver transplanted patients.
    Bilbao I, Castells L, Rojas L, Cancino J, Dopazo C, Castro E, Pou L, Andino R, Margarit C.
    Int Immunopharmacol; 2006 Dec 20; 6(13-14):1977-83. PubMed ID: 17161351
    [Abstract] [Full Text] [Related]

  • 30. Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine.
    Lobritto SJ, Rosenthal P, Bouw R, Leung M, Snell P, Mamelok RD.
    Liver Transpl; 2007 Nov 20; 13(11):1570-5. PubMed ID: 17969194
    [Abstract] [Full Text] [Related]

  • 31. Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey.
    Totri CR, Eichenfield LF, Logan K, Proudfoot L, Schmitt J, Lara-Corrales I, Sugarman J, Tom W, Siegfried E, Cordoro K, Paller AS, Flohr C.
    J Am Acad Dermatol; 2017 Feb 20; 76(2):281-285. PubMed ID: 27855965
    [Abstract] [Full Text] [Related]

  • 32. Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial.
    Haeck IM, Knol MJ, Ten Berge O, van Velsen SG, de Bruin-Weller MS, Bruijnzeel-Koomen CA.
    J Am Acad Dermatol; 2011 Jun 20; 64(6):1074-84. PubMed ID: 21458107
    [Abstract] [Full Text] [Related]

  • 33. [Mycophenolate mofetil after penetrating high risk keratoplasty. A pilot study].
    Reinhard T, Reis A, Kutkuhn B, Voiculescu A, Sundmacher R.
    Klin Monbl Augenheilkd; 1999 Sep 20; 215(3):201-2. PubMed ID: 10528287
    [Abstract] [Full Text] [Related]

  • 34. Tolerability of mycophenolate mofetil in patients with systemic lupus erythematosus.
    Riskalla MM, Somers EC, Fatica RA, McCune WJ.
    J Rheumatol; 2003 Jul 20; 30(7):1508-12. PubMed ID: 12858449
    [Abstract] [Full Text] [Related]

  • 35. Mycophenolate mofetil and atopic dermatitis: systematic review and meta-analysis.
    Phan K, Smith SD.
    J Dermatolog Treat; 2020 Dec 20; 31(8):810-814. PubMed ID: 31294617
    [Abstract] [Full Text] [Related]

  • 36. Methotrexate for Severe Childhood Atopic Dermatitis: Clinical Experience in a Tertiary Center.
    Dvorakova V, O'Regan GM, Irvine AD.
    Pediatr Dermatol; 2017 Sep 20; 34(5):528-534. PubMed ID: 28730617
    [Abstract] [Full Text] [Related]

  • 37. Systemic treatment of pediatric atopic dermatitis with azathioprine and mycophenolate mofetil.
    Waxweiler WT, Agans R, Morrell DS.
    Pediatr Dermatol; 2011 Sep 20; 28(6):689-694. PubMed ID: 21967657
    [Abstract] [Full Text] [Related]

  • 38. Management of severe atopic dermatitis in children.
    Tan AU, Gonzalez ME.
    J Drugs Dermatol; 2012 Oct 20; 11(10):1158-65. PubMed ID: 23134980
    [Abstract] [Full Text] [Related]

  • 39. Systemic treatment for severe atopic dermatitis in children: a case series.
    Cheirif-Wolosky O, Elizalde-Jiménez IG, Romero MTG.
    Bol Med Hosp Infant Mex; 2022 Oct 20; 79(5):310-317. PubMed ID: 36264887
    [Abstract] [Full Text] [Related]

  • 40. Cyclosporine-A for severe childhood atopic dermatitis: clinical experience on efficacy and safety profile.
    Sarıcaoğlu H, Yazici S, Zorlu Ö, Bülbül Başkan E, Aydoğan K.
    Turk J Med Sci; 2018 Oct 31; 48(5):933-938. PubMed ID: 30384556
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.